Kathleen M. McNeeley, Ph.D. - Publications

Affiliations: 
2008 Georgia Institute of Technology, Atlanta, GA 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Kambhampati M, Gittens J, Yadavilli S, Pai SB, McNeeley KM, Becher OJ, Packer RJ, Bellamkonda R, Fernandes R, Nazarian J. HG-64DEVELOPMENT OF IN VIVO DRUG AND GENE DELIVERY SYSTEMS TO BRAIN TUMOR USING LIPOSOMAL NANOCARRIERS Neuro-Oncology. 18: iii62.3-iii62. DOI: 10.1093/Neuonc/Now073.60  0.597
2014 Kambhampati M, Yadavilli S, McNeeley KM, Pai SB, Yu Q, Bellamkonda R, Fernandes R, Packer RJ, Nazarian J. NI-44 * LIPOSOMAL NANOPARTICLES FOR TARGETING AND IMAGING OF PEDIATRIC BRAIN TUMORS Neuro-Oncology. 16: v147-v148. DOI: 10.1093/Neuonc/Nou264.42  0.658
2013 McNeeley K, Lyon JG, Bellamkonda R. Biomaterial strategies to modulate cancer Biomaterials For Cancer Therapeutics: Diagnosis, Prevention and Therapy. 417-444. DOI: 10.1533/9780857096760.4.417  0.573
2011 Loomis K, McNeeley K, Bellamkonda RV. Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications Soft Matter. 7: 839-856. DOI: 10.1039/C0Sm00534G  0.613
2009 Karathanasis E, Chan L, Karumbaiah L, McNeeley K, D'Orsi CJ, Annapragada AV, Sechopoulos I, Bellamkonda RV. Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers. Plos One. 4: e5843. PMID 19513111 DOI: 10.1371/Journal.Pone.0005843  0.581
2009 McNeeley KM, Karathanasis E, Annapragada AV, Bellamkonda RV. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials. 30: 3986-95. PMID 19427688 DOI: 10.1016/J.Biomaterials.2009.04.012  0.628
2009 Karathanasis E, Suryanarayanan S, Balusu SR, McNeeley K, Sechopoulos I, Karellas A, Annapragada AV, Bellamkonda RV. Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology. 250: 398-406. PMID 19188313 DOI: 10.1148/Radiol.2502080801  0.573
2007 McNeeley KM, Annapragada A, Bellamkonda RV. Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma Nanotechnology. 18. DOI: 10.1088/0957-4484/18/38/385101  0.563
2007 Karathanasis E, McNeeley K, Agarwal A, Annapragada A, Bellamkonda R. MR Trackable, Chemotherapeutic Nanoparticles for Patient Specific Glioma Therapy Microscopy and Microanalysis. 13. DOI: 10.1017/S1431927607074909  0.651
Show low-probability matches.